Sera from 31 patients with chronic hepatitis delta virus infection and 18 patients with acute hepatitis delta virus infection were examined for IgA class antibodies to this virus using a newly developed enzyme immunoassay. IgA antibody to hepatitis D virus was detected in 21 (67.7%) of 31 patients w
Antibodies to nuclear lamin C in chronic hepatitis delta virus infection
✍ Scribed by Dr. Józefa Wȩsierska-Ga̧dek; Edward Penner; Eva Hitchman; Georg Sauermann
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 502 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
✦ Synopsis
Sera of patients with chronic hepatitis delta
virus infection stained the nuclear periphery in indirect immunofluorescence. Using proteins of isolated nuclei, isolated nuclear matrices, the nuclear pore complexlamina fraction and purified lamins A and C as antigen source in immunoblotting experiments, nuclear lamin C was identified as the reactive antigen. Most sera tested (8 of 10) recognized nuclear lamin C exclusively, but not the nuclear lamins A and B. Antibodies reacting with both nuclear lamins A and C, which share extensive sequence homologies, have been reported to occur in autoimmune hepatitis and primary biliary cirrhosis. The present 5dings suggest that the novel autoantibody associated with chronic hepatitis delta virus infection recognizes an epitope localized in the short carboxyterminal region of nuclear lamin C. (HEPATOLUGY 1990;12:1129-1133.)
Antibodies t o nuclear antigens are a constant feature of untreated chronic autoimmune or lupoid hepatitis and represent a serological marker in the diagnosis of this disease. During the last decade numerous studies have shown that these sera contain a heterogenous population of nuclear antibodies recognizing nucleic acids, RNA-protein complexes, and centromeric and other proteins (1-4).
Recently a novel antinuclear antibody has been reported to occur in sera of patients with hepatitis delta virus (HDV)-induced chronic hepatitis, which stained the nuclear region in immunofluorescence (5). However, the reacting antigen was not characterized.
In this study we identify nuclear lamin C, a protein of the nuclear envelope, as the major antigen recognized by the antinuclear antibodies in HDV-induced chronic liver disease. Antibodies to nuclear lamins have previously been observed in chronic autoimmune hepatitis and PBC (6, 7). These antibodies, however, recognized both the related nuclear lamins, A and C. The selective recognition of lamin C by sera from patients with HDV-induced chronic liver disease is surprising, consid-
📜 SIMILAR VOLUMES
## Abstract Since hepatitis C virus (HCV) and hepatitis delta virus (HDV) are transmitted by the same routes as hepatitis B virus (HBV), simultaneous or concurrent HCV and HDV infection in patients with chronic HBV infection may occur. To test this hypothesis and to examine the clinicohistological
## Abstract To determine the prevalence and clinical significance of IgM and IgA antibody to hepatitis C virus (HCV) core antigen in chronic HCV infection, sera from 47 patients were tested for immunoglobulin class M (IgM) and immunoglobulin A (IgA) antibody to HCV core antigen by solid‐phase enzym
The significance of circulating antibody to hepatitis C HCV E1 corresponds to the pestiviral gp33/gp25 envevirus (HCV) envelope glycoprotein 2 (E2)/nonstructural lope glycoprotein and the flaviviral envelope protein protein 1 (NS1) glycoprotein was studied in 83 patients (M/E), whereas E2/NS1 corres
To assess possible role of testing for IgM-specific antibody in the diagnosis and monitoring of patients with hepatitis C, we tested sera from 14 patients with acute and 97 patients with chronic non-A, non-B hepatitis for IgG and IgM antibody to hepatitis C virus. IgG antibody to hepatitis C virus w
## Abstract The use of quantitative assays for hepatitis C virus specific antibodies (anti‐HCV) as a prognostic marker was evaluated in 31 patients with chronic hepatitis C treated with interferon (IFN). Changes in titers of serum HCV‐RNA and anti‐HCV antibodies; anti‐C11 (anti‐core), anti‐C100 (an